Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Feher, M. D
Right arrow Articles by Bailey, C. J
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reclassifying insulins

Michael D Feher

Beta Cell Diabetes Centre, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK, michael.feher{at}chelwest.nhs.uk

Clifford J Bailey

Diabetes Research, Pharmaceutical Sciences, Aston University, Birmingham B4 7ET, UK

Insulins have hitherto been distinguished as clear (short-acting) and cloudy (long-acting). However the introduction of glargine, which is a clear long-acting insulin, has prompted the need for reclassification. In view of the increasing emphasis on intensive insulin therapy using basal-bolus regimens, a new, simple, pragmatic classification is suggested in which insulins are categorised according to the timing and purpose of administration: basal (maintenance), bolus (meal) and biphasic (mixed).

Key Words: insulin • basal insulins • bolus insulins • biphasic insulins.

The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 1, 39-42 (2004)
DOI: 10.1177/14746514040040010701
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
A. R Cox and R. E Ferner
Prescribing errors in diabetes
The British Journal of Diabetes & Vascular Disease, March 1, 2009; 9(2): 84 - 88.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
D. R Owens
Review: Insulin glulisine -- the potential for improved glycaemic control
The British Journal of Diabetes & Vascular Disease, March 1, 2007; 7(2): 60 - 66.
[Abstract] [PDF]